On April 12 Beijing time, Slovenian media reported on Luka Doncic's latest situation. He is currently in Slovenia, both spending time with his two daughters and undergoing recovery. Here are the details from the media report—


When Doncic boarded the plane heading to Europe, various speculations arose, with everyone discussing where he might go. Some reports suggested Switzerland or Germany, others mentioned Slovenia, but soon the truth was revealed: Doncic's destination was Spain.
There he underwent a highly specialized stem cell treatment, supervised throughout by Spanish doctor Javier Barria. This doctor currently works for Doncic's former club—Real Madrid.
According to our unofficial but reliable sources, Doncic has completed the first phase of treatment and immediately traveled to Ljubljana after it ended. The reason is self-evident. We all know he has important family matters here—he returned to Slovenia to visit his two daughters, whom he hadn't seen for several months.

Clearly, this series of arrangements by Doncic was also approved by the Los Angeles Lakers. The team undoubtedly fully supports all his decisions: whether traveling to Madrid for treatment or briefly returning to Slovenia between the two phases.
The Lakers are well aware that for their star player, mental health is equally important as physical health. Spending time with his children undoubtedly fills his heart and positively impacts his mental state.
After a brief rest in Slovenia, Doncic will soon return to Madrid for the next phase of treatment. Afterwards, he will fly back to Los Angeles from the Spanish capital to reunite with the Lakers.
The Lakers have one remaining regular-season game, on April 13 against the Jazz. The outcome on the final day will determine the Lakers' final Western Conference ranking and opponent. They have already secured home advantage in the first round, possibly finishing 3rd or 4th in the West, with a first-round opponent being the 5th-ranked Rockets or 6th-ranked Timberwolves. Previous reports indicated Doncic is unlikely to be available for the early part of the first round.